
Bora Pharmaceuticals Co., Ltd. (BORAY) Q2 2026 Earnings Call Transcript
Seeking Alpha
Published: Aug 19, 2026, 03:41 AM GMT+9
SA Transcripts 161.9K Followers Follow Bora Pharmaceuticals Co., Ltd. ( BORAY ) Q2 2026 Earnings Call August 13, 2026 8:00 PM EDT Company Participants Nadiya Chen - Senior Manager of IR/PR Pao-Shi Sheng - Chairman, GM & CEO Presentation Nadiya Chen Senior Manager of IR/PR Welcome, everyone. Thank you for standing by for Bora Pharmaceuticals Second Quarter 2026 Earnings Conference Call. Today, we have Bora Pharmaceuticals Group CEO and Chairman, Bobby Sheng; CFO, Alice Wang with us. [Operator Instructions] Some of the statements that we make today regarding our business, operations and financial performance may be considered forward-looking. Such statements are based on current expectations and assumptions that are subject to a number of risks and uncertainties. Actual results could differ materially. Please refer to our annual and financial reports, including the risk factors. We undertake no obligation to update any forward-looking statements. During this call, we will present both IFRS and non-IFRS financial measures. A reconciliation of the IFRS to non-IFRS measures are included in today's presentation, which is distributed and available to the public through our website. We will now begin our conference call. Bobby, the floor is yours. Pao-Shi Sheng Chairman, GM & CEO Okay. Thank you, everybody, and thank you, all the shareholders and investors for coming on this call, and I will be doing the summary of the 2026 Q2 earnings this year. I think Nadiya went over some the disclaimers here, so we'll move past this slide. So Bora by the numbers, our market cap is USD 1.7 billion. We're the #1 pharma manufacturer in Taiwan. We have now currently 11 manufacturing sites. Now we have over 2,240 employees worldwide, and we export to over 100 countries. You can see on our footprint map here, our footprint in the United States is increasing, especially with the recent acquisition of the Rockville, Maryland biologics facility. So our footprint in the United States is getting bigger and the names of all the facility
Source: Seeking Alpha
This content is not intended as investment advice or a recommendation. Any opinions expressed are solely the personal views of each article.